Researchers are excited about the medication , a novel dual agonist showing remarkable outcomes in initial trials for weight loss . It acts by impacting two pathways : GLP-1 and GIP, that , when engaged https://kobidarw800626.acidblog.net/72014321/this-new-prospect-for-weight-loss